s-; serum; CSF; cerebrospinal fluid; HYP; hypothyroid subjects in our study; CON; healthy control group in our study; PH; primary hypothyroidism in general; f-T3 and f-T4; free unbound thyroid hormone; T3; triiodothyronine; T4; thyroxine; TSH; thyroid stimulating hormone; TPO; thyroid peroxidase antibody; Hb; hemoglobulin; CRP; C reactive protein; BBB; blood brain barrier; M; mean value; NS; non-significant; Md; median value; Q1; first quartile; Q3; third quartile; BSA; body surface area; MCT8; monocarboxylate transporter 8; AHDS; Allan-Herndon-Dudley syndrome; OATP1C1; organic anion transporter polypeptide 1C1; DIO2; type II iodothyronine deiodinase-enzyme; QoL; quality of life; MADRS; Montgomery Asberg Depression Rating Scale; GHLS; General Health Likert Scale;
机译:低CSF /血清比例的自由T4与轻度甲状腺功能亢进的生活质量降低有关 - 试点研究
机译:游离T3与游离T4的比率小于2.0,表明从2岁到18岁,T3综合征的发生率较低,而不是中央甲状腺功能减退症
机译:口服液体或软胶囊中的
机译:血清甲状腺素,游离甲状腺素和甲状腺激素浓度的评价术治理甲状腺功能亢进的诊断
机译:女性甲状腺功能减退症的认知和情感后遗症:与抑郁症的比较,对生活质量的影响以及积极的社会关系的改善作用。
机译:口服液体或软胶囊制剂中的l-甲状腺素可确保中枢性甲状腺功能减退症患者的正常血清游离T4水平更高
机译:低CSF /血清比例的自由T4与轻度甲状腺功能亢进的生活质量降低有关 - 试点研究